Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): A pivotal role of leptin

Respiratory Medicine - Tập 105 - Trang 1046-1053 - 2011
Marie-Kathrin Breyer1,2,3, Erica P.A. Rutten2, Juanita H.J. Vernooy1,2, Martijn A. Spruit2, Mieke A. Dentener1, Carla van der Kallen4, Marleen M.J. vanGreevenbroek4, Emiel F.M. Wouters1,2
1Department of Respiratory Medicine, Maastricht University Medical Centre+ (MUMC+), P.O. Box 5800, 6202 AZ Maastricht, The Netherlands
2Centre of Expertise for Chronic Organ Failure (CIRO), Hornerheide 1, 6085 NM Horn, The Netherlands
3Department of Respiratory and Critical Care Medicine, Ludwig Boltzmann Institute for COPD, Otto Wagner Hospital, Sanatorium Street 2, 1140 Vienna, Austria
4Department of Internal Medicine, Maastricht University Medical Centre+ (MUMC+), P.O. Box 5800, 6202 AZ Maastricht, The Netherlands

Tài liệu tham khảo

Rabe, 2007, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary, Am J Respir Crit Care Med, 176, 532, 10.1164/rccm.200703-456SO Wouters, 2008, COPD: from an organ- to a disease-oriented approach, COPD, 5, 73, 10.1080/15412550801940200 Han, 2007, Gender and chronic obstructive pulmonary disease: why it matters, Am J Respir Crit Care Med, 176, 1179, 10.1164/rccm.200704-553CC Martinez, 2007, Sex differences in severe pulmonary emphysema, Am J Respir Crit Care Med, 176, 243, 10.1164/rccm.200606-828OC Chavannes, 2005, Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients, Fam Pract, 22, 604, 10.1093/fampra/cmi056 Becklake, 1999, Gender differences in airway behaviour over the human life span, Thorax, 54, 1119, 10.1136/thx.54.12.1119 Ahonen, 2008, Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein, Am J Prev Med, 35, 598, 10.1016/j.amepre.2008.09.011 Zabeau, 2003, The ins and outs of leptin receptor activation, FEBS Lett, 546, 45, 10.1016/S0014-5793(03)00440-X Grunfeld, 1996, Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters, J Clin Invest, 97, 2152, 10.1172/JCI118653 Soderberg, 1999, Leptin is associated with increased risk of myocardial infarction, J Intern Med, 246, 409, 10.1046/j.1365-2796.1999.00571.x Soderberg, 1999, Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort, Stroke, 30, 328, 10.1161/01.STR.30.2.328 Abdullah, 2007, Sex differences in the association between leptin and CRP: results from the Dallas Heart Study, Atherosclerosis, 195, 404, 10.1016/j.atherosclerosis.2006.10.022 Tomoda, 2007, Elevated circulating plasma adiponectin in underweight patients with COPD, Chest, 132, 135, 10.1378/chest.07-0227 Sood, 2009, Obesity, adipokines and lung disease, J Appl Physiol Schols, 1999, Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 160, 1220, 10.1164/ajrccm.160.4.9811033 Takabatake, 1999, Circulating leptin in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 159, 1215, 10.1164/ajrccm.159.4.9806134 Brouwers, 2007, Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids, Clin Sci (Lond), 112, 123, 10.1042/CS20060190 Steiner, 2002, Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD, Eur Respir J, 19, 626, 10.1183/09031936.02.00279602 Pouw, 1998, Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 158, 797, 10.1164/ajrccm.158.3.9708097 Petersen, 2007, Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease, Lung, 185, 161, 10.1007/s00408-007-9000-7 Breyer, 2009, Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?, Clin Nutr, 10.1016/j.clnu.2009.05.005 Bastard, 2006, Recent advances in the relationship between obesity, inflammation, and insulin resistance, Eur Cytokine Netw, 17, 4 Kirdar, 2009, Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease, Scand J Clin Lab Invest, 69, 219, 10.1080/00365510802474400 Agrawal, 2008, Gender-based differences in leptinemia in healthy aging, non-obese individuals associate with increased marker of oxidative stress, Int J Clin Exp Med, 1, 305 Machinal-Quelin, 2002, Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue, Endocrine, 18, 179, 10.1385/ENDO:18:2:179 Tommaselli, 2006, Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene, Menopause, 13, 660, 10.1097/01.gme.0000227335.27996.d8 Sin, 2007, Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women, Proc Am Thorac Soc, 4, 671, 10.1513/pats.200706-082SD Bridevaux, 2009, Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD, Eur Respir J, 10.1183/09031936.00162608 Caldefie-Chezet, 2001, Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action?, J Leukoc Biol, 69, 414, 10.1189/jlb.69.3.414 Mercken, 2005, Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 172, 994, 10.1164/rccm.200411-1580OC Chu, 2006, Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin, Am J Obstet Gynecol, 194, 100, 10.1016/j.ajog.2005.06.073 Broekhuizen, 2005, Leptin as local inflammatory marker in COPD, Respir Med, 99, 70, 10.1016/j.rmed.2004.03.029 Vernooy, 2009, Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers, Thorax, 64, 26, 10.1136/thx.2007.085423 Lago, 2007, Adipokines as emerging mediators of immune response and inflammation, Nat Clin Pract Rheumatol, 3, 716, 10.1038/ncprheum0674 Diez, 2003, The role of the novel adipocyte-derived hormone adiponectin in human disease, Eur J Endocrinol, 148, 293, 10.1530/eje.0.1480293 Mojiminiyi, 2007, Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus, Scand J Clin Lab Invest, 67, 215, 10.1080/00365510601032532 Osawa, 2008, Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes, Clin Endocrinol (Oxf), 69, 74, 10.1111/j.1365-2265.2007.03154.x Fontana, 2007, Visceral fat adipokine secretion is associated with systemic inflammation in obese humans, Diabetes, 56, 1010, 10.2337/db06-1656